Bio Plus Balance Sheet Health
Financial Health criteria checks 5/6
Bio Plus has a total shareholder equity of ₩138.1B and total debt of ₩8.6B, which brings its debt-to-equity ratio to 6.2%. Its total assets and total liabilities are ₩172.8B and ₩34.7B respectively. Bio Plus's EBIT is ₩28.0B making its interest coverage ratio -11.8. It has cash and short-term investments of ₩65.0B.
Key information
6.2%
Debt to equity ratio
₩8.63b
Debt
Interest coverage ratio | -11.8x |
Cash | ₩65.00b |
Equity | ₩138.06b |
Total liabilities | ₩34.75b |
Total assets | ₩172.81b |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: A099430's short term assets (₩97.3B) exceed its short term liabilities (₩11.0B).
Long Term Liabilities: A099430's short term assets (₩97.3B) exceed its long term liabilities (₩23.8B).
Debt to Equity History and Analysis
Debt Level: A099430 has more cash than its total debt.
Reducing Debt: Insufficient data to determine if A099430's debt to equity ratio has reduced over the past 5 years.
Debt Coverage: A099430's debt is well covered by operating cash flow (235.1%).
Interest Coverage: A099430 earns more interest than it pays, so coverage of interest payments is not a concern.